BEIJING ( TheStreet) -- Everyone loves a baby, including investors looking to profit from the recent liberalization of China's one-child policy.
Companies that make infant formula, incubators and squeaky toys are getting extra attention from Chinese stock investors now that most of the country's provincial governments have agreed to let more couples have two children.
Because Chinese parents often prefer foreign-brand baby food, global nutrition specialists poised to benefit include Abbott Laboratories
(ABT - Get Report), which this week announced a cooperative investment in China with the New Zealand dairy company Fonterra, and Nestle
(NSRGY), which bought Pfizer's
(PFE - Get Report) baby food business in 2012.
Read More: How Amazon Drones Will Become 'Normal as Seeing Mail Trucks'
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts